|
[Related PubMed/MEDLINE]
Total Number of Papers: 20
|
|
|
|
|
[Display Entries]
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: 2,6-DMA |
| Long Form |
: 2,6-dimethylaniline |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2022 |
Urinary and fecal excretion of aromatic amines in pet dogs and cats from the United States. |
AAs |
| 2 |
2022 |
Variability in urinary concentrations of primary aromatic amines. |
2-NA, 4-CA, AAs, DF, FMV, ICCs, OSBs, p-CD, p-TD |
| 3 |
2021 |
Primary aromatic amines in indoor dust from 10 countries and associated human exposure. |
2,4-DAT, 2-NA, 4,4'-MDA, 4-CA, AAs, EDI, p-CD, p-TD |
| 4 |
2018 |
Measurement of lidocaine and 2,6-dimethylaniline in minipig plasma, skin, and dermal tapes using UHPLC with electrospray MS/MS. |
--- |
| 5 |
2018 |
Targeted and Untargeted Detection of DNA Adducts of Aromatic Amine Carcinogens in Human Bladder by Ultra-Performance Liquid Chromatography-High-Resolution Mass Spectrometry. |
2-MA, 2-NA, 4-ABP, AAs, FFPE, FR, LPO, nt, wide-SIM |
| 6 |
2018 |
[A novel dispersive liquid-liquid microextraction method with high performance liquid chromatography for detection of 2,6-dimethylaniline in lidocaine hydrochloride injection]. |
DLLME, EF, HFIP, HPLC-UV, LOD, SUPRAS |
| 7 |
2016 |
Photoinduced electron transfer interaction of anthraquinones with aniline quenchers: Influence of methyl substitution in aniline donors. |
2,3-DMA, 3,5-DMA, AN, AQ, AQS, CAQ, DFT, ET, N,N-DMA |
| 8 |
2014 |
Cytoplasmic and nuclear toxicity of 3,5-dimethylaminophenol and potential protection by selenocompounds. |
3,5-DMA, 3,5-DMAP, 3-EA, ROS, Se, SM, SS, TrxR |
| 9 |
2014 |
Protective effects of ascorbic acid against the genetic and epigenetic alterations induced by 3,5-dimethylaminophenol in AA8 cells. |
3,5-DMA, 3,5-DMAP, 3-EA, ASC, CHO, MAAs, ROS |
| 10 |
2013 |
Elevated 4-aminobiphenyl and 2,6-dimethylaniline hemoglobin adducts and increased risk of bladder cancer among lifelong nonsmokers--The Shanghai Bladder Cancer Study. |
ABP, CI |
| 11 |
2011 |
Oxidation of 2,6-dimethylaniline by the Fenton, electro-Fenton and photoelectro-Fenton processes. |
PE-F, UV |
| 12 |
2009 |
Kinetics and mechanism of 2,6-dimethyl-aniline degradation by hydroxyl radicals. |
--- |
| 13 |
2008 |
Kinetics of 2,6-dimethylaniline degradation by electro-Fenton process. |
--- |
| 14 |
2003 |
Determination of 2,6-dimethylaniline and o-toluidine impurities in preparations for local anaesthesia by the HPLC method with amperometric detection. |
o-TLD |
| 15 |
2002 |
The effect of deuterium and fluorine substitution upon the mutagenicity of N-hydroxy-2,6-dimethylaniline. |
--- |
| 16 |
2001 |
Oxidation of 2,6-dimethylaniline by recombinant human cytochrome P450s and human liver microsomes. |
DMAP, DMHA |
| 17 |
1997 |
Pharmacokinetics and metabolism of the novel anticonvulsant agent N-(2,6-dimethylphenyl)-5-methyl-3-isoxazolecarboxamide (D2624) in rats and humans. |
--- |
| 18 |
1993 |
Simultaneous determination of xylazine and its major metabolite, 2,6-dimethylaniline, in bovine and swine kidney by liquid chromatography. |
CV, LC, SD, XY |
| 19 |
1989 |
Covalent binding of [14C]-2,6-dimethylaniline to DNA of rat liver and ethmoid turbinate. |
AAF, CBI |
| 20 |
1989 |
The in vivo oxidative metabolism of 2,4- and 2,6-dimethylaniline in the dog and rat. |
2,4-DMA, 2-AMBA, 3-MC, 4-AMBA, 4-HDMA, 6-HDMA, AAMBA |
|
A Search Service for Abbreviation / Long Form
